LabTurbo Biotech Corporation

7725 · TWO · Healthcare / Biotechnology

21.00TWD+0.15 (+0.72%)

Price History

Full chart

Market Stats

Previous Close20.85

Open21.00

Day Range20.50 – 21.00

52-Week Range20.58 – 25.88

Volume12.00K

Market Cap1.10B

P/E (TTM)0.00

Forward P/E0.00

EPS-0.81

Dividend Yield0.87%

50-Day Avg22.62

200-Day Avg23.20

About

LabTurbo Biotech Corporation engages in the research, manufacture, and sale of gene detection systems and kits in Taiwan, the United States, the Czech Republic, Spain, France, Israel, Singapore, the Philippines, and Malaysia. It serves hospitals. The company was founded in 2000 and is based in Taipei, Taiwan.

Company Details

SectorHealthcare
IndustryBiotechnology
HeadquartersNo. 150, Chengde Rd., Taipei, Taiwan, 111, Taiwan
Websitehttps://labturbo.com

Financials

Income Statement

Currency: TWD	2021-12-31	2022-12-31	2023-12-31	2024-12-31
Total Revenue	979.46M	1.34B	188.09M	72.97M
Growth (%)	-	+37.03%	-85.99%	-61.20%
Cost of Revenue	295.06M	346.71M	156.97M	55.95M
Gross Profit	684.40M	995.45M	31.13M	17.02M
Gross Margin	69.88%	74.17%	16.55%	23.33%
Operating Expense	100.20M	197.06M	209.88M	199.53M
Operating Income	584.20M	798.39M	-178.75M	-182.51M
Operating Margin	59.64%	59.49%	-95.03%	-250.10%
EBITDA	599.64M	865.02M	-8.87M	53.53M
EBITDA Margin	61.22%	64.45%	-4.71%	73.35%
Net Income	458.50M	642.78M	-64.35M	12.96M
Net Income Margin	46.81%	47.89%	-34.21%	17.76%
R&D	31.77M	66.18M	82.08M	84.76M
R&D as % of Total Revenue	3.24%	4.93%	43.64%	116.14%
Interest Expense	726.00K	550.00K	169.00K	486.00K
Interest Expense % of Total Revenue	0.07%	0.04%	0.09%	0.67%

Balance Sheet

Currency: TWD	2021-12-31	2022-12-31	2023-12-31	2024-12-31
Total Assets	1.36B	1.78B	1.40B	1.39B
Total Liabilities	304.25M	240.03M	66.01M	76.13M
Total Equity	1.06B	1.54B	1.34B	1.31B
Cash	604.72M	714.05M	294.03M	175.62M
Total Debt	52.66M	42.47M	10.87M	28.16M
Net Debt	-552.07M	-671.58M	-283.16M	-147.46M

Cash Flow

Currency: TWD	2021-12-31	2022-12-31	2023-12-31	2024-12-31
Operating Cash Flow	255.53M	861.34M	-149.59M	-120.58M
Investing Cash Flow	-34.38M	-578.80M	-94.60M	46.30M
Financing Cash Flow	203.94M	-172.90M	-177.00M	-45.02M
Capital Expenditure	124.33M	59.95M	26.73M	19.90M
Free Cash Flow	131.20M	801.38M	-176.31M	-140.48M
Dividends Paid	18.94M	144.98M	144.98M	24.16M
FCF to OCF	51.35%	93.04%	117.87%	116.51%
Dividend Paid to FCF	14.43%	18.09%	-82.23%	-17.20%

Key Statistics & Ratios

Market Cap1.10B

Enterprise Value272.73M

Trailing P/E0.00

Forward P/E0.00

Price / Sales11.36

Price / Book0.92

EPS-0.81

Revenue (TTM)0

Gross Profit (TTM)0

Profit Margin0.00%

Operating Margin0.00%

Return on Equity0.00%

Return on Assets0.00%

Shares Outstanding47.94M

Shares Float0

Dividend Yield0.87%

Dividend Rate0.20

Payout Ratio0.00%

Dividends

20261×

0.20Jul 8, 2026

20251×

0.30Jul 2, 2025

20241×

0.50Jun 26, 2024